{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:39:46Z","timestamp":1791175186850,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11096-015-0068-5","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T02:32:23Z","timestamp":1422412343000},"page":"355-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Statin adverse effects: patients\u2019 experiences and laboratory monitoring of muscle and liver injuries"],"prefix":"10.1007","volume":"37","author":[{"given":"Nataporn","family":"Chaipichit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Krska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thongchai","family":"Pratipanawatr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumol","family":"Jarernsiripornkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"68_CR1","unstructured":"World Health Organization. The 10 leading causes of death, 2010 and 2011. http:\/\/www.who.int\/gho\/mortality_burden_disease\/causes_death\/mbd_013.jpg . Accessed 15 Dec 2014."},{"issue":"25 Pt B","key":"68_CR2","first-page":"2889","volume":"63","author":"NJ Stone","year":"2013","unstructured":"Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;63(25 Pt B):2889\u2013934.","journal-title":"J Am Coll Cardiol"},{"key":"68_CR3","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 106(25):3143\u2013421.","DOI":"10.1161\/circ.106.25.3143"},{"issue":"2","key":"68_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.amjcard.2012.03.023","volume":"110","author":"SS Martin","year":"2012","unstructured":"Martin SS, Metkus TS, Horne A, Blaha MJ, Hasan R, Campbell CY, et al. Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendations. Am J Cardiol. 2012;110(2):307\u201313.","journal-title":"Am J Cardiol"},{"issue":"1","key":"68_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2006.01.005","volume":"28","author":"MA Silva","year":"2006","unstructured":"Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: a meta-analysis. Clin Ther. 2006;28(1):26\u201335.","journal-title":"Clin Ther"},{"key":"68_CR6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","volume":"93","author":"PH Jones","year":"2003","unstructured":"Jones PH, Davidson MH, Stein EA, Bays HE, Mckenney JM, Miller E, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR*Trial). Am J Cardiol. 2003;93:152\u201360.","journal-title":"Am J Cardiol"},{"key":"68_CR7","unstructured":"Consumers Union of United States, Inc. Consumer reports best buy drugs\u2122. Evaluating statin drugs to treat: high cholesterol and heart disease-comparing effectiveness, safety, and price. http:\/\/www.consumerreports.org\/health\/resources\/pdf\/best-buy-drugs\/StatinsUpdate-FINAL.pdf . Accessed 15 Dec 2014."},{"issue":"8A","key":"68_CR8","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","volume":"97","author":"JM McKenney","year":"2006","unstructured":"McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the national lipid association statin safety assessment task force. Am J Cardiol. 2006;97(8A):89C\u201394C.","journal-title":"Am J Cardiol"},{"key":"68_CR9","unstructured":"FDA Consumer Health Information, U.S. Food and Drug Administration. FDA expands advice on statin risks. http:\/\/www.fda.gov\/downloads\/ForConsumers\/ConsumerUpdates\/UCM293705.pdf . Accessed 15 Dec 2014."},{"issue":"8A","key":"68_CR10","doi-asserted-by":"crossref","first-page":"77C","DOI":"10.1016\/j.amjcard.2005.12.014","volume":"97","author":"DE Cohen","year":"2006","unstructured":"Cohen DE, Anania FA, Chalasani N. An assessment of statin safety by hepatologists. Am J Cardiol. 2006;97(8A):77C\u201381C.","journal-title":"Am J Cardiol"},{"issue":"8A","key":"68_CR11","doi-asserted-by":"crossref","first-page":"69C","DOI":"10.1016\/j.amjcard.2005.12.013","volume":"97","author":"PD Thompson","year":"2006","unstructured":"Thompson PD, Clarkson PM, Rosenson RS. An assessment of statin safety by muscle experts. Am J Cardiol. 2006;97(8A):69C\u201376C.","journal-title":"Am J Cardiol"},{"issue":"8","key":"68_CR12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmjqs-2011-000213","volume":"21","author":"JK Ward","year":"2012","unstructured":"Ward JK, Armitage G. Can patients report patient safety incidents in a hospital setting? A systematic review. BMJ Qual Saf. 2012;21(8):685\u201399.","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"68_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/11594320-000000000-00000","volume":"35","author":"F Hunsel van","year":"2012","unstructured":"van Hunsel F, Harmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35(1):45\u201360.","journal-title":"Drug Saf"},{"issue":"10","key":"68_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03261977","volume":"35","author":"J Inch","year":"2012","unstructured":"Inch J, Watson MC, Anakwe-Umeh S. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Drug Saf. 2012;35(10):807\u201318.","journal-title":"Drug Saf"},{"issue":"5","key":"68_CR15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/11589320-000000000-00000","volume":"34","author":"J Krska","year":"2011","unstructured":"Krska J, Anderson C, Murphy E, Avery AJ. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK yellow card scheme. Drug Saf. 2011;34(5):429\u201336.","journal-title":"Drug Saf"},{"issue":"3","key":"68_CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/pds.1708","volume":"18","author":"N Jarernsiripornkul","year":"2009","unstructured":"Jarernsiripornkul N, Kakaew W, Loalukkana W, Krska J. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Pharmacoepidemiol Drug Saf. 2009;18(3):240\u20135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"68_CR17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11096-009-9310-3","volume":"31","author":"N Jarernsiripornkul","year":"2009","unstructured":"Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, Krska J. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharm World Sci. 2009;31(5):559\u201364.","journal-title":"Pharm World Sci"},{"issue":"1","key":"68_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2012.03.023","volume":"24","author":"N Jarernsiripornkul","year":"2012","unstructured":"Jarernsiripornkul N, Senacom P, Uchaipichat V, Chaipichit N, Krska J. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. Epilepsy Behav. 2012;24(1):102\u20136.","journal-title":"Epilepsy Behav"},{"issue":"9","key":"68_CR19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40264-013-0055-5","volume":"36","author":"P Boonmuang","year":"2013","unstructured":"Boonmuang P, Nathisuwan S, Chaiyakunapruk N, Suwankesawong W, Pokhagul P, Teerawattanapong N, Supsongserm P. Characterization of statin-associated myopathy case reports in thailand using the health product vigilance center database. Drug Saf. 2013;36(9):779\u201387.","journal-title":"Drug Saf"},{"issue":"8","key":"68_CR20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00002018-200730080-00003","volume":"30","author":"BA Golomb","year":"2007","unstructured":"Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007;30(8):669\u201375.","journal-title":"Drug Saf"},{"issue":"3","key":"68_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.0306-5251.2001.01547.x","volume":"53","author":"N Jarernsiripornkul","year":"2002","unstructured":"Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53(3):318\u201325.","journal-title":"Br J Clin Pharmacol"},{"key":"68_CR22","unstructured":"Lacy CF. American Pharmacists Association. Drug information handbook: a comprehensive resource for all clinicians and healthcare professionals. 20th edn. Lexi-Comp, Ohio 2011\u20132012. ISBN: 978-1-59195-292-3."},{"issue":"4","key":"68_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacl.2011.05.005","volume":"5","author":"LJ Harris","year":"2011","unstructured":"Harris LJ, Thapa R, Brown M, Pabbathi S, Childress RD, Heimberg M, Braden R, Elam MB. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia. J Clin Lipidol. 2011;5(4):299\u2013307.","journal-title":"J Clin Lipidol"},{"issue":"7","key":"68_CR24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","volume":"354","author":"VJ Navarro","year":"2006","unstructured":"Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"68_CR25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.26719\/2011.17.5.460","volume":"17","author":"SO Mashayekhi","year":"2011","unstructured":"Mashayekhi SO, Ghandforoush-Sattari M, Baghdadchi ME, Kheyri M. Patients\u2019 report of statins use and side-effects in a sample of hospitalized cardiac patients in the Islamic Republic of Iran. East Mediterr Health J. 2011;17(5):460\u20134.","journal-title":"East Mediterr Health J"},{"issue":"4","key":"68_CR26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-144-4-200602210-00007","volume":"144","author":"S Bent","year":"2006","unstructured":"Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med. 2006;144(4):257\u201361.","journal-title":"Ann Intern Med"},{"issue":"5","key":"68_CR27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2125.2009.03400.x","volume":"67","author":"F Hunsel van","year":"2009","unstructured":"van Hunsel F, Passier A, van Grootheest K. Comparing patients\u2019 and healthcare professionals\u2019 ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol. 2009;67(5):558\u201364.","journal-title":"Br J Clin Pharmacol"},{"issue":"8, Suppl 1","key":"68_CR28","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.amjcard.2005.12.010","volume":"97","author":"M Law","year":"2006","unstructured":"Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol. 2006;97(8, Suppl 1):S52\u201360.","journal-title":"Am J Cardiol"},{"issue":"4","key":"68_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/mcp.2009.0365","volume":"85","author":"RM Calderon","year":"2010","unstructured":"Calderon RM, Cubeddu LX, Goldberg RB, Schiff ER. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc. 2010;85(4):349\u201356.","journal-title":"Mayo Clin Proc"},{"key":"68_CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00228-007-0283-7","volume":"63","author":"P Lampela","year":"2007","unstructured":"Lampela P, Hartikainen S, Sulkava R, Huupponen R. Adverse drug effects in elderly people\u2014a disparity between clinical examination and adverse effects self-reported by the patient. Eur J Clin Pharmacol. 2007;63:509\u201315.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"68_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1525-1497.2000.04199.x","volume":"15","author":"TK Gandhi","year":"2000","unstructured":"Gandhi TK, Burstin HR, Cook EF, Puopolo AL, Haas JS, Brennan TA, Bates DW. Drug complications in outpatients. J Gen Intern Med. 2000;15(3):149\u201354.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"68_CR32","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/annonc\/mdp287","volume":"20","author":"M Cirillo","year":"2009","unstructured":"Cirillo M, Venturini M, Ciccarelli L, Coati F, Bortolami O, Verlato G. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient\u2019s self-reported questionnaire. Ann Oncol. 2009;20(12):1929\u201335.","journal-title":"Ann Oncol"},{"issue":"1","key":"68_CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2318-10-37","volume":"10","author":"J Thomson","year":"2010","unstructured":"Thomson J, Wang W, Browning C, Kendig H. Self-reported medication side effects in an older cohort living independently in the community\u2014the Melbourne Longitudinal Study on Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk factors. BMC Geriatr. 2010;10(1):37.","journal-title":"BMC Geriatr"},{"issue":"3","key":"68_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/pubmed\/fdi031","volume":"27","author":"A Bowling","year":"2005","unstructured":"Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health. 2005;27(3):281\u201391.","journal-title":"J Public Health"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-015-0068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-015-0068-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-015-0068-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T01:44:45Z","timestamp":1566265485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-015-0068-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s11096-015-0068-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,29]]}}}